International audienceDNA gyrase is a major bacterial protein that is involved in replication and transcription and catalyzes the negative supercoiling of bacterial circular DNA. DNA gyrase is a known target for antibacterial agents since its blocking induces bacterial death. Quinolones, coumarins, and cyclothialidines have been designed to inhibit gyrase. Significant improvements can still be envisioned for a better coumarin-gyrase interaction. In this work, we obtained the crystal costructures of the natural coumarin clorobiocin and a synthetic analogue with the 24 kDa gyrase fragment. We used isothermal titration microcalorimetry and differential scanning calorimetry to obtain the thermodynamic parameters representative of the molecular ...
DNA gyrase is a type II topoisomerase that catalyzes the introduction of negative supercoils in the ...
DNA gyrase and topoisomerase IV are proven to be validated targets in the design of novel antibacter...
Antibiotics targeting DNA gyrase have been a clinical success story for the past half-century, and t...
International audienceDNA gyrase is a major bacterial protein that is involved in replication and tr...
Bacterial DNA gyrase, has been identified as the target of several antibacterial agents, including t...
Coumermycin A1 is a natural aminocoumarin that inhibits bacterial DNA gyrase, a member of the GHKL p...
Simocyclinone D8, a coumarin derivative isolated from Streptomyces antibioticus Tu\ua8 6040, represe...
AbstractThe aminocoumarin antibiotics clorobiocin, novobiocin, and coumermycin A1 are inhibitors of ...
The coumarin antibiotics are potent inhibitors of DNA replication whose target is the enzyme DNA gyr...
DNA gyrase is the enzyme from bacteria which is unique among type II topoisomerases in its ability t...
The rapidly increasing rate of antibiotic resistance is of great concern. Approximately two million ...
Type II topoisomerases like DNA gyrase initiate ATP-dependent negative supercoils in bacterial DNA. ...
Quinolones are a clinically-useful class of antibacterial agents known to target DNA gyrase, a bacte...
AbstractSimocyclinone D8 (SD8) is an antibiotic produced by Streptomyces antibioticus that targets D...
The impacts of multi-drug resistant bacteria have an estimated global cost of $40 billion and provid...
DNA gyrase is a type II topoisomerase that catalyzes the introduction of negative supercoils in the ...
DNA gyrase and topoisomerase IV are proven to be validated targets in the design of novel antibacter...
Antibiotics targeting DNA gyrase have been a clinical success story for the past half-century, and t...
International audienceDNA gyrase is a major bacterial protein that is involved in replication and tr...
Bacterial DNA gyrase, has been identified as the target of several antibacterial agents, including t...
Coumermycin A1 is a natural aminocoumarin that inhibits bacterial DNA gyrase, a member of the GHKL p...
Simocyclinone D8, a coumarin derivative isolated from Streptomyces antibioticus Tu\ua8 6040, represe...
AbstractThe aminocoumarin antibiotics clorobiocin, novobiocin, and coumermycin A1 are inhibitors of ...
The coumarin antibiotics are potent inhibitors of DNA replication whose target is the enzyme DNA gyr...
DNA gyrase is the enzyme from bacteria which is unique among type II topoisomerases in its ability t...
The rapidly increasing rate of antibiotic resistance is of great concern. Approximately two million ...
Type II topoisomerases like DNA gyrase initiate ATP-dependent negative supercoils in bacterial DNA. ...
Quinolones are a clinically-useful class of antibacterial agents known to target DNA gyrase, a bacte...
AbstractSimocyclinone D8 (SD8) is an antibiotic produced by Streptomyces antibioticus that targets D...
The impacts of multi-drug resistant bacteria have an estimated global cost of $40 billion and provid...
DNA gyrase is a type II topoisomerase that catalyzes the introduction of negative supercoils in the ...
DNA gyrase and topoisomerase IV are proven to be validated targets in the design of novel antibacter...
Antibiotics targeting DNA gyrase have been a clinical success story for the past half-century, and t...